Management

Governance Documents | Board of Directors | Management | Committee Composition  
Jay R. Luly, Ph.D.
President, Chief Executive Officer and Director
Jay R. Luly, Ph.D.
President, Chief Executive Officer and Director


Dr. Luly joined Enanta in July 2003.

Prior to joining Enanta, Dr. Luly was an Entrepreneur in Residence at Oxford Bioscience Partners. Before joining Oxford in March 2002, Dr. Luly held the positions of Senior Vice President, Research and Development Operations and Senior Vice President, Discovery Strategy and Operations at Millennium Pharmaceuticals following Millennium’s merger with LeukoSite, Inc., where he had served as Senior Vice President, Drug Discovery and Preclinical Devel... 

Yat Sun Or, Ph.D.
Senior Vice President, Research & Development and Chief Scientific Officer
Yat Sun Or, Ph.D.
Senior Vice President, Research & Development and Chief Scientific Officer


Dr. Or joined Enanta in November 1999.

Prior to joining Enanta, Dr. Or held key leadership positions at Abbott Laboratories from 1985 to 1999, where he received two Chairman’s Awards for his outstanding research, which led to the discovery and development of numerous immunosuppressant and antibacterial drugs. Prior to Abbott, Dr. Or was a member of the cardiovascular drug discovery team at Schering-Plough.

Dr. Or received his Ph.D. in Organic Chemistry from the University... 

Paul J. Mellett
Senior Vice President, Finance & Administration and Chief Financial Officer
Paul J. Mellett
Senior Vice President, Finance & Administration and Chief Financial Officer


Mr. Mellett joined Enanta in September 2003.

From April 2001 through August 2003, he held the position of Senior Vice President and Chief Financial Officer of Essential Therapeutics. Previously, Mr. Mellett was the Chief Financial Officer and Vice President of Administration at GelTex Pharmaceuticals, Inc., a publicly held biotechnology company that was acquired by Genzyme Corporation in December 2000. From 1994 to 1997, Mr. Mellett served as Chief Financial Officer of Marshall Con... 

Timothy D. Ocain, Ph.D.
Senior Vice President, New Product Strategy & Development
Timothy D. Ocain, Ph.D.
Senior Vice President, New Product Strategy & Development


Dr. Ocain joined Enanta in 2014.

Since 2010, Dr. Ocain has been an independent biotechnology consultant providing consulting services to a variety of companies. From 2006-2009, he was a member of the executive team as the Senior Vice President, Research and Development at Seaside Therapeutics, a company focused on neurodevelopmental disorders. Previously, he worked at Millennium Pharmaceuticals from 1998-2006 and held positions of increasing responsibility in drug discovery, progr... 

Nathaniel S. Gardiner, J.D.
Senior Vice President and General Counsel
Nathaniel S. Gardiner, J.D.
Senior Vice President and General Counsel


Mr. Gardiner joined Enanta in May of 2014.

Previously he was a corporate and securities law partner for 25 years, starting at Palmer & Dodge LLP and continuing through its merger into Edwards Angell Palmer & Dodge LLP, which is now known as Edwards Wildman Palmer LLP. Since 2008 Mr. Gardiner had been co-chair of the firm’s Life Sciences Group, and before that he was co-chair of the Business Law Department. In his private practice, Mr. Gardiner was Enanta’s outside counsel and Secretary s... 

Email Alerts

Sign up to receive email alerts whenever Enanta Pharmaceuticals Inc posts new information to the site.

Just enter your email address and click Submit.
 
 ;